Forme moléculaire And NotZ. Gadhoum

List of bibliographic references

Number of relevant bibliographic references: 7.

Ident.	Authors (with country if any)	Title
002B99	Catharine M. Sturgeon [Royaume-Uni] ; Peter Berger [Autriche] ; Jean-Michel Bidart [France] ; Steven Birken [États-Unis] ; Chris Burns [Royaume-Uni] ; Robert J. Norman [Australie] ; Ulf-Hakan Stenman [Finlande]	Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic Gonadotropin
002E61	Ana S. Guerreiro [Suisse] ; Sarah Fattet [France, Suisse] ; Barbara Fischer [Suisse] ; Tarek Shalaby [Suisse] ; Shaun P. Jackson [Australie] ; Simone M. Schoenwaelder [Australie] ; Michael A. Grotzer [Suisse] ; Olivier Delattre [France] ; Alexandre Arcaro [Suisse]	Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
004623	Adrian Bristow [Royaume-Uni] ; Peter Berger [Autriche] ; Jean-Michel Bidart [France] ; Steven Birken [États-Unis] ; Robert Norman [Australie] ; Ulf-Hakan Stenman [Finlande] ; Catharine Sturgeon [Royaume-Uni]	Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin
005365	D. R. Richardson [Australie]	Iron chelators as therapeutic agents for the treatment of cancer
005734	Anne-Sophie Vercoutter-Edouart [France] ; Jérome Lemoine [France] ; Xuefen Le Bourhis [France] ; Hornez Louis [France] ; Bénoni Boilly [France] ; Victor Nurcombe [Australie] ; Francoise Revillion [France] ; Jean-Philippe Peyrat [France] ; Hubert Hondermarck [France]	Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells
006005	P. Brooks [Australie] ; P. Emery [Royaume-Uni] ; J. F. Evans [États-Unis] ; H. Fenner [Suisse] ; C. J. Hawkey [Royaume-Uni] ; C. Patrono [Italie] ; J. Smolen [Autriche] ; F. Breedveld [Pays-Bas] ; R. Day [Australie] ; M. Dougados [France] ; E. W. Ehrich [États-Unis] ; J. Gijon-Banos [Espagne] ; T. K. Kvien [Norvège] ; M. H. Van Rijswijk [Pays-Bas] ; T. Warner [Royaume-Uni] ; H. Zeidler [Allemagne]	Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
006429	K. M. Webber [Australie] ; C. A. Wallace [Australie] ; A. I. Smith [Australie] ; M. Van Den Buuse [Australie]	Endothelin interactions with brain dopamine systems

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024